Tirzepatide Stability: How It Degrades and How to Slow It

Tirzepatide is chemically robust for a 39-residue peptide: its sequence has no methionine, cysteine, histidine or asparagine, so the fastest degradation reactions seen in other peptides have nowhere to start. Its main chemical risks in solution are light-driven oxidation at one tryptophan and two tyrosines and slow changes at two glutamines and two aspartates. Its bigger risk is physical: self-association driven by its C20 fatty diacid. Cold, dark, still storage slows all of these.

This page walks through those routes residue by residue against the sequence in PubChem (CID 163285897). The storage windows themselves are on how long tirzepatide lasts: sealed powder cold and dark, and a vial mixed with bacteriostatic water kept at 2 to 8 °C for 8 to 12 weeks, with quality slowly fading from around week 6 to 8.

Chemical routes in the sequence

Tryptophan and tyrosine oxidation, and light

With no methionine or cysteine, the residues most open to oxidation are Trp25 and the tyrosines at positions 1 and 10. Tryptophan oxidises mainly under light, especially ultraviolet, and in the presence of trace metals or peroxides, and its products are often faintly yellow; tyrosine can form dityrosine cross-links under the same conditions (Manning et al., Pharmaceutical Research, 2010). Phe6 and Phe22 absorb ultraviolet light too. The US prescribing information for the approved medicine tells users to protect it from heat and light and keep it in its carton, which fits this chemistry.

Deamidation at Gln19 and Gln24

Glutamine side chains can lose ammonia and become glutamic acid. For glutamine this is far slower than for asparagine (Manning et al., 2010), and tirzepatide has no asparagine. Gln19 sits between Ala18 and the acylated Lys20, and Gln24 between Val23 and Trp25; none of these neighbours is glycine, the residue that most speeds the reaction. Neither glutamine is at the N-terminus, so pyroglutamate cyclisation does not apply.

Aspartate isomerisation at Asp9 and Asp15

Aspartic acid can cyclise through a succinimide and reopen as isoaspartate, a reaction that is fastest before glycine and other small residues (Geiger and Clarke, Journal of Biological Chemistry, 1987). Tirzepatide’s aspartates are followed by Tyr10 and Lys16, bulkier neighbours that slow it. There are no Asp-Gly or Asp-Pro bonds, so acid-catalysed backbone cleavage at Asp-Pro is absent. Low pH and heat favour this route.

The lipid chain, linker and Aib residues

The diacid is a saturated C20 chain, 1,20-eicosanedioic acid in the prescribing information, so it does not oxidise the way an unsaturated fat would. Its gamma-glutamic acid and AEEA linker are joined by amide bonds that are stable at fridge temperature. The alpha-methylated Aib residues at positions 2 and 13 are themselves very resistant to chemical change.

Physical stability: self-association

For tirzepatide the physical route matters more than the chemical ones. Lipidation changes how incretin peptides behave in water: in a systematic study of five lipidated GLP-1 analogues, lipidation narrowed the pH range in which the peptides stayed soluble, increased helical structure, and produced larger and more stable oligomers than the unmodified peptide, with some analogues going on to form fibrils or amorphous aggregates over 6 days (Přáda Brichtová et al., Bioconjugate Chemistry, 2025). Semaglutide, a related lipidated analogue, formed dimers and trimers at lower concentrations and slowly assembled into micelles, with a small population of short fibrils, at higher ones (Hamley et al., Biomacromolecules, 2025). In glucagon, a relative, hydrophobic patches drive fibrillation (Pedersen et al., Biochemistry, 2006); tirzepatide carries one at Phe22 to Ile27.

Soluble oligomers are normal and invisible. What harms the solution is anything that pushes them further, into visible aggregates: warmth, shaking, repeated freezing, air bubbles and a pH that drifts toward the peptide’s isoelectric region.

Lyophilised versus reconstituted

Dry, tirzepatide is very stable because every reaction above needs water to proceed. The cake’s real enemies are moisture and warmth, which is why a cold vial is brought to room temperature before the stopper is pierced, so that condensation does not form on the powder. Once mixed, the clock starts: chemical change is slow but continuous, and physical association depends on how the vial is treated. No published stability study covers tirzepatide reconstituted in bacteriostatic water, so the 8 to 12 week window is general peptide guidance.

Temperature, freeze-thaw and pH

Temperature. Each route above speeds up as temperature rises, so a mixed vial lives at 2 to 8 °C and comes out only for handling.

Freeze-thaw. Freezing concentrates the peptide between ice crystals and creates ice surfaces, both of which drive amphiphilic molecules together. The prescribing information is direct: do not freeze, and do not use if frozen. A working vial is not frozen; laboratories needing longer holds freeze single-use aliquots once.

pH. Tirzepatide is acidic overall, with five carboxyl groups against two basic groups, so it is most soluble and least prone to association near neutral pH; the approved solution is formulated at pH 6.5 to 7.5. Acidic conditions approach its isoelectric region, where charge repulsion is lowest; see the tirzepatide solubility guide.

What visible changes mean

• Brief haze straight after mixing that clears in 10 to 15 minutes: normal wetting of a lipidated cake.
• Haze that persists or returns: self-association into aggregates.
• Strands, flakes or settled particles: aggregation after shaking, warmth or freezing.
• Yellow tint: tryptophan or tyrosine oxidation, usually after light exposure.
• Thickening or gel: high concentration with agitation; see why peptides gel or go cloudy.

A clear, colourless solution inside its refrigerated window is the expected state. Any of the changes above, or a vial past week 12 in the fridge, is best replaced. Bench steps that protect stability are on the tirzepatide handling page.